Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Mizuho analyst Haendel St. Juste downgraded VICI Properties Inc (NYSE:VICI) from Outperform to Neutral and maintained the price target of $30. VICI Properties shares closed at $29.31 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Anupam Rama downgraded Day One Biopharmaceuticals Inc (NASDAQ:DAWN) from Overweight to Neutral and cut the price target from $27 to $21.5. Day One Biopharmaceutical shares closed at $21.31 on Tuesday. See how other analysts view this stock.
- UBS downgraded Telefonica Brasil SA (NYSE:VIV) from Buy to Sell. Telefonica Brasil shares closed at $16.09 on Tuesday. See how other analysts view this stock.
Considering buying VICI stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments